Developer docs
API playgroundTry for free, no card

Search company profiles

Africa Health Ventures

Full company profile

uuid000l9ry

Namestring
Africa Health Ventures
Legal namestring
Africa Health Ventures
Websiteurl
africahealthventures.com
Company typeenum
Private
Founded yearstring
-
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCape Town, South Africa
HQ citystring
Cape Town
HQ countrystring
South Africa
HQ regionstring
Africa
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare venture capital, early-stage investing, healthtech startups, pre-seed funding, seed-stage funding
Industry1 code
1FSANAJAI
CodeFSANAJAIPrimaryYes
NAICS code1 code
  • 523940
SIC code1 code
  • 6282
Product category
Healthcare Venture Capital
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management
TypeManaged Services
Description

As a healthcare-specific venture fund, Africa Health Ventures likely generates revenue through traditional VC fund economics: management fees on committed capital during the fund lifecycle and carried interest (carry) on returns above the hurdle rate distributed to LPs once portfolio companies achieve exits.

africahealthventures.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Africa Health Ventures is a healthcare-specific venture capital fund that invests in pre-seed and seed-stage healthtech startups targeting African markets. The firm provides founder-friendly capital alongside healthcare-specific domain expertise and founder/innovator networks to unlock markets and scale portfolio companies across impact and profit dimensions.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Africa Health Ventures is an early-stage venture capital fund that invests in pre-seed and seed stage healthtech startups targeting African markets. The firm provides founder-friendly capital along with access to healthcare-specific networks and domain expertise to unlock markets and grow portfolio companies. Africa Health Ventures does not offer a unified product platform but operates as an investment vehicle supporting a portfolio of distinct healthtech companies.

Product and service3 records
1Pre-seed and Seed Healthcare Venture Capital Funding
CategoryVenture Capital Investment
2Africa Healthcare Venture Insights Newsletter (Substack)
CategoryContent / Community
3Africa Healthcare Ventures Podcast
CategoryContent / Community
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Adjuvant Capital
TypeDirect peer
Description

Specialist health venture fund targeting life sciences and healthtech for underserved markets. Comparable in healthcare-specific mandate and impact orientation, though geographic focus is broader than Africa-only.

2The Steele Foundation for Hope
TypeDirect peer
Description

Co-investor with Africa Health Ventures in AI Diagnostics. Funds early-stage health and impact ventures; directly comparable as a co-participant in African healthtech rounds of similar size.

3Global Innovation Fund
TypeDirect peer
Description

Co-investor with Africa Health Ventures in AI Diagnostics. Funds breakthrough innovations for developing-country markets, including health, with comparable early-stage check sizes and African deal flow.

4Ingressive Capital
TypeRegional player
Description

Pan-African VC investing in tech startups with partial exposure to healthtech. Comparable stage and Africa focus, though tech-generalist rather than health-specialist.

5Novastar Ventures
TypeDirect peer
Description

Africa-focused venture firm backing early-stage consumer and healthcare businesses across East and Southern Africa. Directly comparable as another specialist early-stage investor targeting African growth markets with similar check sizes.

6Savannah Fund
TypeDirect peer
Description

Pan-African seed fund investing in early-stage tech startups across the continent. Comparable mandate, stage, and geography, with overlap in early digital health investments.

7TLcom Capital
TypeBroad incumbent
Description

Africa-focused venture firm with a broader tech mandate across sectors including healthtech. Comparable in stage and geography but broader portfolio focus and typically larger fund sizes.

8Partech Africa
TypeBroad incumbent
Description

Pan-African venture fund backing early- to growth-stage startups across multiple sectors. Comparable geography and stage range but significantly larger fund and broader sector mandate.

9Acumen
TypeBroad incumbent
Description

Global impact investor with a long-standing Africa health portfolio. Comparable in impact-driven health investing thesis and African footprint, though typically larger check sizes and longer hold periods.

10LeapFrog Investments
TypeBroad incumbent
Description

Emerging-markets impact investor with material exposure to African healthcare and financial services. Comparable in health-focused emerging-markets thesis, though typically targets growth-stage rather than pre-seed/seed.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment3 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Africa Health Ventures

Healthcare Venture Capitalafricahealthventures.com

Africa Health Ventures firmographics

Firmographics
Name
Africa Health Ventures
Legal name
Africa Health Ventures
Website
https://africahealthventures.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Where Africa Health Ventures is headquartered

Location

Headquarters

HQ city
Cape Town
HQ country
South Africa
HQ region
Africa

Offices1 record

Markets served

Africa Health Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Fund Management: As a healthcare-specific venture fund, Africa Health Ventures likely generates revenue through traditional VC fund economics: management fees on committed capital during the fund lifecycle and carried interest (carry) on returns above the hurdle rate distributed to LPs once portfolio companies achieve exits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Africa Health Ventures product offering

Product offering

Core offering

Africa Health Ventures is a healthcare-specific venture capital fund that invests in pre-seed and seed-stage healthtech startups targeting African markets. The firm provides founder-friendly capital alongside healthcare-specific domain expertise and founder/innovator networks to unlock markets and scale portfolio companies across impact and profit dimensions.

Product overview

Africa Health Ventures is an early-stage venture capital fund that invests in pre-seed and seed stage healthtech startups targeting African markets. The firm provides founder-friendly capital along with access to healthcare-specific networks and domain expertise to unlock markets and grow portfolio companies. Africa Health Ventures does not offer a unified product platform but operates as an investment vehicle supporting a portfolio of distinct healthtech companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pre-seed and Seed Healthcare Venture Capital Funding
  • Africa Healthcare Venture Insights Newsletter (Substack)
  • Africa Healthcare Ventures Podcast

Companies that use Africa Health Ventures

Customer profile

Segments1 record

Ideal customer profiles1 record

Africa Health Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Africa Health Ventures partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Africa Health Ventures competitors and assessment

Company assessment

Direct peers

  • Adjuvant Capital: Specialist health venture fund targeting life sciences and healthtech for underserved markets. Comparable in healthcare-specific mandate and impact orientation, though geographic focus is broader than Africa-only.
  • The Steele Foundation for Hope: Co-investor with Africa Health Ventures in AI Diagnostics. Funds early-stage health and impact ventures; directly comparable as a co-participant in African healthtech rounds of similar size.
  • Global Innovation Fund: Co-investor with Africa Health Ventures in AI Diagnostics. Funds breakthrough innovations for developing-country markets, including health, with comparable early-stage check sizes and African deal flow.
  • Novastar Ventures: Africa-focused venture firm backing early-stage consumer and healthcare businesses across East and Southern Africa. Directly comparable as another specialist early-stage investor targeting African growth markets with similar check sizes.
  • Savannah Fund: Pan-African seed fund investing in early-stage tech startups across the continent. Comparable mandate, stage, and geography, with overlap in early digital health investments.

Regional players

  • Ingressive Capital: Pan-African VC investing in tech startups with partial exposure to healthtech. Comparable stage and Africa focus, though tech-generalist rather than health-specialist.

Broad incumbents

  • TLcom Capital: Africa-focused venture firm with a broader tech mandate across sectors including healthtech. Comparable in stage and geography but broader portfolio focus and typically larger fund sizes.
  • Partech Africa: Pan-African venture fund backing early- to growth-stage startups across multiple sectors. Comparable geography and stage range but significantly larger fund and broader sector mandate.
  • Acumen: Global impact investor with a long-standing Africa health portfolio. Comparable in impact-driven health investing thesis and African footprint, though typically larger check sizes and longer hold periods.
  • LeapFrog Investments: Emerging-markets impact investor with material exposure to African healthcare and financial services. Comparable in health-focused emerging-markets thesis, though typically targets growth-stage rather than pre-seed/seed.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Africa Health Ventures social profiles

Digital presence

Africa Health Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Africa Health Ventures leadership team

Management profile

Number of profiles

Profiles1 record

Africa Health Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Africa Health Ventures M&A and investment

M&A and investment

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Africa Health Ventures

What does Africa Health Ventures do?

Africa Health Ventures is a healthcare-specific venture capital fund that invests in pre-seed and seed-stage healthtech startups targeting African markets. The firm provides founder-friendly capital alongside healthcare-specific domain expertise and founder/innovator networks to unlock markets and scale portfolio companies across impact and profit dimensions.

Is Africa Health Ventures a public or private company?

Africa Health Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Africa Health Ventures founded?

Africa Health Ventures was founded in -1. It employs 1 to 10 people.

Where is Africa Health Ventures based?

Africa Health Ventures is headquartered in Cape Town, South Africa, in the Africa region.

How does Africa Health Ventures make money?

One revenue line is on record: fund Management.

Who are Africa Health Ventures's main competitors?

Direct peers on record are Adjuvant Capital, The Steele Foundation for Hope, Global Innovation Fund, Novastar Ventures and Savannah Fund. Ingressive Capital is listed as a regional player. Broad incumbents are TLcom Capital, Partech Africa, Acumen and LeapFrog Investments.

Does Africa Health Ventures have an API?

No public API is recorded for Africa Health Ventures.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EntarabiMENA Startups Raise $96.1 Million in Two Weeks as Saudi Arabia Leads Fintech InvestmentMENA startups raised $96.1 million in funding across seven disclosed rounds between July 12 and 26, with Saudi Arabia leading at $84 million. Fintech attracted $77 million, and Saudi fintech Fina secured $75 million in Shariah-compliant financing.DisruptafricaEgyptian e-health startup Reme-D raises $1.45m pre-Series A fundingEgyptian e-health startup Reme-D has raised US$1.45 million in pre-Series A funding led by Anara Impact Capital, with participation from Global Innovation Fund, Africa Health Ventures, and other investors. The funds will be used to expand manufacturing capacity, regional footprint, and diagnostic product portfolio, including new tests for genetic diseases and cancer, with a focus on temperature-resilient diagnostics for underserved African markets. Since its 2023 launch, the company has developed 30 diagnostic products and supplied over 550,000 tests across Egypt, Kenya, and Sudan.WeeTrackerEgyptian Biotech Reme-D Raises USD 1.45 M Pre-Series A To Expand Molecular DiagnosticsEgyptian healthtech startup Reme-D has raised USD 1.45 million in a Pre-Series A round led by Anara Impact Capital, with participation from the Global Innovation Fund and Africa Health Ventures, to expand its molecular diagnostics business. Founded in 2023, the Cairo-based company develops diagnostic tests for tuberculosis, HIV, hepatitis, and HPV, and has supplied over 550,000 tests across Egypt, Kenya, and Sudan. The new funding will increase Reme-D's manufacturing capacity tenfold and support regional expansion beyond its current 30 diagnostic products.TechAfrica NewsEgyptian Healthtech Reme-D Raises $1.45M to Expand Molecular DiagnosticsReme-D, an Egyptian healthtech company developing molecular diagnostic solutions, has closed a $1.45 million Pre-Series A funding round led by Anara Impact Capital, with participation from Global Innovation Fund, Africa Health Ventures, and other investors. The funds will be used to expand manufacturing capacity, regional reach, and product portfolio, including new tests for genetic diseases and cancer. Since 2023, the company has commercialized 30 diagnostic products and supplied over 550,000 tests across Egypt, Kenya, and Sudan.IncubeesAnara Impact Capital led $1.45 M investment raised by Egypt’s Reme-D – IncubeesReme-D, an Egyptian healthtech company developing molecular diagnostic solutions, has closed a $1.45 million Pre-Series A funding round led by Anara Impact Capital with participation from the Global Innovation Fund and Africa Health Ventures. The funds will support expansion of manufacturing capacity, regional reach, and product portfolio, including new tests for genetic diseases and cancer-related diagnostics. The company, which has grown from 5 to 50 employees since 2023 and developed 30 diagnostic products, plans to move to a larger facility to increase capacity tenfold and expand market access across Africa.AllafricaAfrica: Egypt's Reme-D Gets $1.45m to Scale Molecular Diagnostics in AfricaEgyptian healthtech startup Reme-D has raised $1.45 million in a Pre-Series A funding round led by Anara Impact Capital, with participation from the Global Innovation Fund, Africa Health Ventures and other investors, to expand production of molecular diagnostic tests and grow across Africa. The funding will support higher manufacturing capacity, regional expansion, and development of new diagnostic products including tests for tuberculosis, HIV, hepatitis and HPV. Founded in 2023 and based in Cairo, Reme-D has developed 30 diagnostic products and supplied over 550,000 tests across Egypt, Kenya and Sudan, and plans to move into a new 1,500-square-meter manufacturing facility to increase production capacity tenfold.TechawkEgyptian Diagnostics Startup Reme-D Raises $1.45m to Scale Local Testing ProductionEgyptian diagnostic startup Reme-D has closed a $1.45 million Pre-Series A round led by Anara Impact Capital, with participation from Global Innovation Fund, Africa Health Ventures and other backers. The funding will be used to grow its Cairo production site, expand into new African markets, and add cancer and genetic disease screening to its product line focused on infectious disease testing. Over three years, the company has brought 30 diagnostic products to market and delivered over 550,000 tests to healthcare providers in Egypt, Kenya and Sudan.Lucidity InsightsReme-D Raises US$1.45M Pre-Series AReme-D, an Egyptian healthtech startup, raised US$1.45 million in pre-Series A funding led by Anara Impact Capital. The capital will expand manufacturing capacity 10x, relocate to a 1,500 sqm facility, and develop new diagnostic tests. The company has supplied over 550,000 tests across Egypt, Kenya, and Sudan since 2023.CoinMarketCapEgyptian health startup Reme-D raises $1.45M in funding round to acquire new diagnostic tools: Guest Post by Technext.ngEgyptian healthtech company Reme-D has raised $1.45 million in a Pre-Series A funding round led by Anara Impact Capital, with participation from the Global Innovation Fund and Africa Health Ventures. The capital will be used to reinforce development of diagnostic tools for genetic diseases and cancer and expand the company's manufacturing capacity tenfold. Founded in 2023, Reme-D has developed 30 diagnostic products and supplied over 550,000 tests across Egypt, Kenya, and Sudan.TechMoranAnara Backs Egyptian Healthtech Startup Reme-D in $1.45 Million : TechMoranEgyptian health technology startup Reme-D has raised $1.45 million in a Pre-Series A funding round led by Anara Impact Capital, with participation from the Global Innovation Fund, Africa Health Ventures, and existing investors. The funding will finance a tenfold expansion in manufacturing capacity, development of new diagnostic tests for cancer and genetic diseases, and geographic expansion across Africa and the Middle East. Founded in 2023 by Salma Tammam, Cairo-based Reme-D produces molecular diagnostic tests for diseases including tuberculosis, HIV, hepatitis, and HPV, with a focus on temperature-resilient kits designed for regions with unreliable infrastructure.